Comparing Tafinlar vs Zelboraf
| Tafinlar Remove Tafinlar from your drug comparison | Zelboraf Remove Zelboraf from your drug comparison |
|---|
| Tafinlar dabrafenib Remove Tafinlar from your drug comparison | Zelboraf vemurafenib Remove Zelboraf from your drug comparison | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Thyroid Cancer, Melanoma - Metastatic, Non-Small Cell Lung Cancer. Tafinlar may also be used for purposes not listed in this medication guide. |
Prescribed for Erdheim-Chester Disease, Melanoma - Metastatic. Zelboraf may also be used for purposes not listed in this medication guide. |
||||||||||||||||
|
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews |
|||||||||||||||||
Drug Class |
|||||||||||||||||
Side Effects |
|||||||||||||||||
|
Common side effects include: squamous cell carcinoma, fever, and hyperglycemia. See the full Tafinlar side effects document. |
Common side effects include: squamous cell carcinoma, keratoacanthoma, skin photosensitivity, and erythema of skin. See the full Zelboraf side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||||||||||
View all Tafinlar prices |
View all Zelboraf prices |
||||||||||||||||
Generic Availability |
|||||||||||||||||
|
No |
No |
||||||||||||||||
Dosage Form(s) Available |
|||||||||||||||||
|
|
||||||||||||||||
Brand Names |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||||||||||
|
22 hours |
120 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
|||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
|||||||||||||||||
|
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||||||||||
Drug Interactions |
|||||||||||||||||
|
A total of 426 drugs are known to interact with Tafinlar:
|
A total of 545 drugs are known to interact with Zelboraf:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions |
|||||||||||||||||
First Approval Date |
|||||||||||||||||
|
May 29, 2013 |
August 17, 2011 |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
More Information |
|||||||||||||||||
Consumer Resources |
|||||||||||||||||
Professional Resources |
|||||||||||||||||
Related Treatment Guide |
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.